Table 3.
Lymph-nodal characteristics after contrast administration.
Characteristics of adenopathies | Tot (37) | <5 (23) | ≥ 5 (14) | Confirmed TB (30) | Probable TB (7) | P |
---|---|---|---|---|---|---|
Ring | 6 (16.2) | 4 (17.3) | 2 (14.3) | 4 (13.3) | 2 (28.6) | Ns |
Non-homogeneous | 1 (2.7) | - | 1 (7.1) | 1 (3.3) | - | Ns |
Homogeneous | 15 (40.5) | 10 (43.5) | 5 (35.7) | 11 (36.7) | 4 (57.1) | Ns |
Calcifications | 10 (27) | 5 (21.7) | 5 (35.7) | 7 (23.3) | 3 (42.9) | Ns |
Pointed | 4 (10.8) | 2 (8.7) | 2 (14.3) | 3 (10) | 1 (14.3) | Ns |
Shell | 5 (13.5) | 3 (13.4) | 2 (14.3) | 3 (10) | 2 (28.6) | Ns |
Moriform | 1 (2.7) | - | 1 (7.1) | 1 (3.3) | - | Ns |
Size | Ns | |||||
<1 cm | 9 (24.3) | 6 (26.1) | 3 (21.4) | 7 (23.3) | 2 (28.6) | Ns |
1-2 | 18 (48.6) | 12 (52.2) | 6 (42.8) | 16 (53.3) | 2 (28.6) | |
>2 cm | 6 (16.2) | 3 (13.0) | 3 (21.4) | 4 (13.3) | 2 (28.6) | |
NO linf | 4 (10.8) | 2 (8.7) | 2 (14.3) | 3 (10) | 1 (14.3) | |
Lymphnode as only pathological finding | 4 (10.8) | 4 (17.3) | - | 2 (6.67) | 2 (28.6) | Ns |
NS, Not significant.